Ristova 100 mg Injection
  1. Home
  2. Pharma Products
  3. Cipla Ltd
  4. Ristova 100 mg Injection

Ristova 100 mg Injection

Ristova 100 mg Injection contains rituximab 100 mg, a monoclonal antibody used for certain blood cancers and autoimmune conditions. It is administered by intravenous infusion under the supervision of a qualified healthcare professional. Rituximab targets CD20-positive B cells and helps reduce abnormal B-cell activity.

BUY NOW

Category

Ristova 100 mg Injection is used in conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and certain blood-vessel disorders. Rituximab binds to the CD20 antigen on B cells and promotes their removal through immune-mediated mechanisms. The dose and infusion schedule are determined by the treating specialist according to the patient’s condition and treatment protocol. Medical supervision during administration is important because infusion-related reactions may occur.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 100 mg
Dosage Form Concentrate for Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 10 mL in 1 Vial
Manufacturer/Marketer Roche Products India Pvt Ltd / Cipla Ltd.

Product Also Known As

Ristova 100 mg Injection, Ristova 100 Injection, Ristova Rituximab Injection, Rituximab 100 mg Injection, Rituximab 100 mg/10 mL Infusion, Rituximab Monoclonal Antibody Injection